期刊文献+

内耳损伤的修复与再生

原文传递
导出
摘要 噪声、药物、重金属等因素可导致内耳损伤。内耳损伤的研究发现,不同机制不同类型的损伤通常始发于内耳的特定区域。本文集中探讨内耳损伤后,对特定区域的干预以帮助内耳损伤后的修复与再生。
作者 周琦 尹时华
出处 《国际耳鼻咽喉头颈外科杂志》 2011年第6期317-320,共4页 International Journal of Otolaryngology-Head and Neck Surgery
  • 相关文献

参考文献1

二级参考文献40

  • 1Steiner, H., Holtl, L., Wirtenberger, W., Berger, A. P., Bartsch, G., and Hobisch, A. (2002). Long term experience with carboplatin monotherapy for clinical stage I seminoma: a retrospective single center study. Urology 60, 324-328.
  • 2Ettinger, D. S. (1998). The role of carboplatin in the treatment of small-cell lung cancer. Oncology (Huntingt) 12, 36-43.
  • 3Cavaletti, G., Bogliun, G., Zincone, A., Marzorati, L., Melzi, P., Frattola, L., Marzola, M., Bonazzi, C., Cantu, M. G., Chiari, S., Galli, A., Bregni, M., and Gianni, M. (1998). Neuro and ototoxicity of high dose carboplatin treatment in poor prognosis ovarian cancer patients. Anticancer Res. 18, 3797-3802.
  • 4Bohm, S., Oriana, S., Spatti, G., DiRe, F., Breasciani, G., Pirovano, C., Grosso, I., Martini, C., Caraceni, A., Pilotti, S., and Zunini, F. (1999). Dose intensification of platinum compounds with glutathione protection as induction chemotherapy for advanced ovarian carcinoma. Oncology 57, 115-120.
  • 5Wandt, H., Birkmann, J., Denzel, T., Schafer, K., Schwab, G., Pilz, D., Egger, H., Both, A., and Gallmeir, W. M. (1999). Sequential cycles of high dose chemotherapy with dose escalation carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer. Bone Marrow Transplant 23, 763-770.
  • 6Simon, T., Hero, B., Dupuis, W., Selle, B., and Berthold, F. (2002). The incidence if hearing impairment after successful treatment of neuroblastoma. Klin. Padiatr. 214, 149-152.
  • 7Obermair, A., Speiser, P., Thoma, M., Kaider, A., Salzer, H., Dittrich, C., and Sevelda, R. (1998). Prediction of toxicity but not of clinical course by determining carboplatin exposure in patients with epithelial ovarian cancer treated with a combination of carboplatin and cisplatin. Int. J. Oncol. 13, 1023-1030.
  • 8Neuwelt, E. A., Brummet, R. E., Doolittle, N. D., Maldoon, L. L., Kroll, R. A., Pagel, M. A., Dojan, R., Church, V., Remsen, L. G., and Bubalo, J. S. (1998). First evidence of otoprotection against caboplatin-induced hearing loss with a two compartment system in patient with central nervous system malignancy using sodium thiosulfate. J. Pharmacol. Exp. Therap. 286, 77-84.
  • 9Husain, K., Scott, R. B., Whitworth, C., Somani, S. M., and Rybak, L. P. (2001a). Dose response of carboplatin-induced hearing loss in rats: antioxidant defense system. Hear. Res. 151, 71-78.
  • 10Hu, B. H., McFadden, S. L., Salvi, R. J., and Henderson, D. (1999). Intracochlear infusion of buthionine sulfoximine potentiates carboplatin ototoxicity in the chinchilla. Hear. Res. 128, 125-134.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部